— Know what they know.
Not Investment Advice
Also trades as: BALAJITELE.NS (NSE) · $vol 0M

BALAJITELE.BO BSE

Balaji Telefilms Limited
1W: -4.8% 1M: -3.5% 3M: -2.1% YTD: -4.9% 1Y: -2.9% 3Y: +103.0% 5Y: +38.3%
₹89.46 ($0.93)
-2.03 (-2.22%)
 
BSE · Communication Services · Entertainment · Tech Score Neutral · Power 45 · ₹10.9B mcap · 49M float · 0.040% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap₹10.9B ($113.5M)
52W Range70-132.55
Volume15,310
Avg Volume19,735
Beta0.63
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOSanjay Dwivedi
Employees105
SectorCommunication Services
IndustryEntertainment
IPO Date2002-07-01
C-13, Balaji House
Mumbai, MA 400053
IN
91 22 4069 8000
About Balaji Telefilms Limited

Balaji Telefilms Limited, founded in 1994 and based in Mumbai, India, is a prominent player in the entertainment industry, with operations extending across both domestic and international markets. The company's business activities are categorized into three core areas: Commissioned Programmes, Films, and Digital ventures. Under its flagship "Balaji Telefilms" brand, the company specializes in producing and distributing a wide range of television content and feature films, primarily in Hindi. In addition to scripted productions, it also organizes reality shows and various live events. Within its digital segment, Balaji Telefilms operates "ALT Balaji," a brand that provides both business-to-consumer (B2C) and business-to-business (B2B) digital content. This digital arm is also responsible for generating new intellectual property, managing "Hoonur" – a platform designed for media professionals and entertainment enthusiasts – and running its own subscription-based over-the-top (OTT) video-on-demand service.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms